EPISODE · May 12, 2025 · 42 MIN
Spyros Papapetropoulos, CEO of Neuphoria
from Power to the Patients · host Brandon Li
Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros delves into his transition from practicing neurologist to drug development and his decision to focus on neuropsychiatric diseases. They explore Neuphoria's innovative approach to treating social anxiety disorder with their lead program, BNC210, which has shown promising results in reducing anxiety without the side effects of current treatments. Spyros and Brandon discuss unmet needs in psychiatric treatments, the operational challenges in clinical trials, and the evolving landscape of neuroscience - including the exciting advancements in imaging, biomarkers, and precision psychiatry.
What this episode covers
Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros delves into his transition from practicing neurologist to drug development and his decision to focus on neuropsychiatric diseases. They explore Neuphoria's innovative approach to treating social anxiety disorder with their lead program, BNC210, which has shown promising results in reducing anxiety without the side effects of current treatments. Spyros and Brandon discuss unmet needs in psychiatric treatments, the operational challenges in clinical trials, and the evolving landscape of neuroscience - including the exciting advancements in imaging, biomarkers, and precision psychiatry.
NOW PLAYING
Spyros Papapetropoulos, CEO of Neuphoria
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m